Natural Killer Cells in Innate Immunity and Cancer

This publication has 80 references indexed in Scilit:

• IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
  Blood, 2006
• Bortezomib and Depsipeptide Sensitize Tumors to Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand: A Novel Method to Potentiate Natural Killer Cell Tumor Cytotoxicity
  Cancer Research, 2006
• IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-β in NK cells via the c-Jun N-terminal kinase (JNK) pathway
  Cellular Immunology, 2006
• A Phase I Study of Ultra Low Dose Interleukin-2 and Stem Cell Factor in Patients with HIV Infection or HIV and Cancer
  Clinical Cancer Research, 2006
• Evidence for discrete stages of human natural killer cell differentiation in vivo
  The Journal of Experimental Medicine, 2006
• NK-cell activation by LIGHT triggers tumor-specific CD8+ T-cell immunity to reject established tumors
  Blood, 2006
• Role of antibody-dependent cell-mediated cytotoxicity in the efficacy of therapeutic anti-cancer monoclonal antibodies
  Cancer and Metastasis Reviews, 2005
• Natural Killer Cell–Mediated Lysis of Hepatoma Cells via Specific Induction of NKG2D Ligands by the Histone Deacetylase Inhibitor Sodium Valproate
  Cancer Research, 2005
• Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells
  The Journal of Experimental Medicine, 2004
• In search of the ‘missing self’: MHC molecules and NK cell recognition
  Published by Elsevier ,2003